Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches
- PMID: 32448762
- DOI: 10.1016/j.tim.2020.04.003
Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches
Abstract
Cytomegalovirus (CMV) infection elicits a potent immune response that includes the stimulation of antibodies with neutralizing activity. Recent studies have focused on elucidating the role of neutralizing antibodies in protecting against CMV infection and disease and characterizing viral antigens against which neutralizing antibodies are directed. Here, we provide a synthesis of recent data regarding the role of neutralizing antibodies in protection against CMV infection/disease. We consider the role of humoral immunity in the context of the global CMV-specific immune response, and the implications that recent findings have for vaccine and antibody-based therapy design.
Keywords: CMV-specific immune response; antibody-based therapeutics; cytomegalovirus; neutralizing antibodies; vaccine design.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Disclaimer Statement M.J.M. and P.P.R. are founders and shareholders of Vaxdyn, S.L., a biotechnology company developing vaccines.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
